Vol. 16 No. 2 (2012)
CONGENITAL HEART DISEASES

Results of tricuspid valve replacement with various types of prosthesis in children

Yu. Gorbatykh
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
Yu. Naberukhin
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
Ye. Lenko
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
A. Omelchenko
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
T. Khapaev
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
Ye. Zhalnina
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio
V. Shilenko
Academician E.N. Meshalkin Novosibirsk Research Institute of Circulation Pathology
Bio

Published 2012-07-03

Keywords

  • TRICUSPID VALVE REPLACEMENT,
  • CHILDREN,
  • MECHANICAL PROSTHESES,
  • BIOPROSTHESIS

How to Cite

Gorbatykh, Y., Naberukhin, Y., Lenko, Y., Omelchenko, A., Khapaev, T., Zhalnina, Y., & Shilenko, V. (2012). Results of tricuspid valve replacement with various types of prosthesis in children. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 16(2), 9–14. https://doi.org/10.21688/1681-3472-2012-2-9-14

Abstract

The article presents immediate and long-term results of tricuspid valve replacement in a pediatric group. Two subgroups were studied: the first group included children who received bioprostheses (n=66), while the second subgroup consisted of patients with mechanical valves (n=46). The factors considered to be associated with mortality were young age and weight, as well as a higher NYHA functional class before surgery. The data obtained suggests that hospital mortality does not depend on the type of implanted prosthesis. The average time of reoperation in children with mechanical valves was 6.9±3.9 years, while that in the subgroup with bioprostheses 4.7±1.8 years. No significant advantages in the clinical course in the immediate postoperative period among the subgroups were revealed.

References

  1. Бокерия Л.А., Серов Р.А., Свободов А.А. и др. // Детские болезни сердца и сосудов. 2006. № 6. С. 65-71.
  2. Nakano K., Ishibashi-Ueda H., Kobayashi J. et al. // Ann. Thorac. Surg. 2001. V. 71. P. 105-109.
  3. Бокерия Л.А., Подзолков В.П., Малашенков А.И. и др. // Грудная и сердечно-сосудистая хирургия. 2002. № 1. С. 4-11.
  4. Dalrymple-Hay M.J., Leung Y., Ohri S.K. et al. // J. Heart Valve Dis. 1999. V. 8. P. 644-648.
  5. Guenther T., Noebauera G., Mazzitellia D. et al. // Eur. J. Cardiothorac. Surg. 2008. V. 34. P. 402-409.
  6. Brown M.L., Dearani J.A., Danielson G.K. et al. // Am. J. Cardiology. 2009. V. 103. P. 555-561.
  7. Sasahashi N., Ando F., Okamoto F. et al. // Kyobu Geka. 1999. V. 52 (4). P. 269-273.
  8. Curcio C.A., Commerford PJ., Rose A.G. et al. // J. Thorac. Cardiovasc. Surg. 1981. V. 81. P. 621-625.
  9. Kaplan M., Kut M.S., Demirtas M.M. et al. // Ann. Thorac. Surg. 2002. V. 73. P. 467-473.
  10. Long C.Z., Zhou X.M., Hu J.G. et al. // Zhonghua Yi Xue Za Zhi. 2005. V. 85 (26). P. 1849-1852.
  11. Rizzoli G., Vendramin I., Nesseris G. et al. // Ann. Thorac. Surg. 2004. V. 77. P. 1607-1614.
  12. Carrier M., Hebert Y., Pellerin M. et al. // Ann. Thorac. Surg. 2003. V. 75. P. 47-50.
  13. Kunadian B., Vijayalakshmi K. et al. // Cardiovasc. Thorac. Surg. 2008. V. 10. P. 123-125.